NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1437595311 MD
Verify on CMS → Amy Shah, MD
Endocrinology, Diabetes & Metabolism Physician in Dallas, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 245 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
40%
generic claims · 51% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
74.6/100
▼ 9 pts below national avg 83.5 · Mid-tier
Industry payments
$142.95
2 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Amy Shah, MD reported a CMS MIPS final score of 74.6/100 - below the 83.5 national average - and filed 1,587 Medicare Part D claims in 2023.
- 74.6/100
- MIPS score · -9 vs avg
- 2K
- Part D claims, 2023
- 40%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Amy Shah, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
75 ≥ 13th percentile 13% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Amy Shah, MD sits
This provider among endocrinology, diabetes & metabolism physician peers
Across the 2,341 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Amy Shah, MD writes more Part D claims than 38% of them and scores higher on MIPS quality than 15% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Amy Shah, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Amy Shah, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Amy Shah, MD?
Below national averagePrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
1,587 40% vs specialty avg
MIPS final score
74.6/100 8.9 pts vs avg
Specialty distribution in Texas
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Texas providers
Medicare quality performance, MIPS
Amy Shah, MD's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average
- MIPS Final Score
- 74.6/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Amy Shah, MD appears in the CMS NPPES registry as an Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 2001 INWOOD RD, Dallas, TX, 75390, with a listed phone of (214) 645-2800. NPI 1437595311 was issued on 05/17/2013.
Medicare Part D records for calendar year 2023 show 1,587 prescription claims written by this provider, covering 245 Medicare beneficiaries and totaling roughly $880K in drug spend, split 51% brand-name and 40% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 74.6/100 for the 2023 performance year (Quality 56.1, Cost 59.2), compared with the 83.5 average among clinicians with a measured score.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,871 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1437595311 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 05/17/2013 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
74.5984
Final Score
Measured-score avg: 83.5
56.1252
Quality
59.2027
Cost
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Amy Shah, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
University OF Texas Southwestern Medical Center AT Dallas
Dallas, TX
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Amy Shah, MD. Source: openpaymentsdata.cms.gov.
Total received
$143
Largest payer
Eli Lilly and Company
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Amy Shah, MD. To verify Amy Shah, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Amy Shah, MD - brand share 51.0%
Endocrinology, Diabetes & Metabolism Physician average
51% brand-name claims vs 40% generic, on 1,587 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,587
Total Claims
$880K
Total Drug Cost
245
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 3,592
- Total Day Supply
- 106,363
- Brand vs Generic
- 51% brand / 40% generic
- Brand Drug Cost
- $842K
- Generic Drug Cost
- $17K
Patient Demographics
- Average Patient Age
- 67.8 years
- Avg HCC Risk Score
- 2.27
- Gender Split
- 56% female / 44% male
- Age Distribution
- <65: 66, 65-74: 119, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Amy Shah, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Ozempic
Ozempic
157 claims
- Levothyroxine Sodium
Levothyroxine Sodium
135 claims
- Metformin Hcl Er
Metformin Hcl Er
79 claims
- Jardiance
Jardiance
76 claims
- Atorvastatin Calcium
Atorvastatin Calcium
73 claims
- Hydrocortisone 61
Hydrocortisone
61 claims
- Mounjaro 45
Mounjaro
45 claims
- Metformin Hcl 43
Metformin Hcl
43 claims
| Drug | Claims |
|---|---|
| Ozempic Semaglutide | 157 |
| Levothyroxine Sodium | 135 |
| Metformin Hcl Er Metformin Hcl | 79 |
| Jardiance Empagliflozin | 76 |
| Atorvastatin Calcium | 73 |
| Hydrocortisone | 61 |
| Mounjaro Tirzepatide | 45 |
| Metformin Hcl | 43 |
| Novolog Flexpen Insulin Aspart | 42 |
| Methimazole | 35 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in TX →
All providers in Texas →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Amy Shah, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Amy Shah, MD's 1,587 claims are below the specialty average of 2,639.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Shah, both outside Texas so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (74.6 here).
Same NPPES enumeration year (2013)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Shah.
One of 520 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Texas, 5 are shown here.
Dr. Nicola Abate
MD
Baytown, TX
Dr. Jessica Abramowitz
MD
Dallas, TX
Dr. Layla Abushamat
M.D., M.P.H.
Houston, TX
Dr. Luis Acosta
MD
Houston, TX
Dr. Stefanie Addington
M.D.
Frisco, TX
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Endocrinology, Diabetes & Metabolism Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Texas
Frequently Asked Questions
What is Amy Shah, MD's specialty? ▼
Amy Shah, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Dallas, Texas. Credentials: MD.
How much does Amy Shah, MD prescribe under Medicare Part D? ▼
In 2023, Amy Shah, MD wrote 1,587 Medicare Part D claims totaling $880K in drug costs for 245 beneficiaries.
What is Amy Shah, MD's Medicare quality score? ▼
Amy Shah, MD has a CMS MIPS Final Score of 74.6/100 (Quality: 56.1, Cost: 59.2). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Amy Shah, MD located? ▼
Amy Shah, MD is located at 2001 INWOOD RD, Dallas, TX, 75390. Phone: (214) 645-2800.
What is Amy Shah, MD's NPI number? ▼
Amy Shah, MD's National Provider Identifier (NPI) is 1437595311, issued on 05/17/2013.
Does Amy Shah, MD prescribe more brand-name or generic drugs? ▼
Amy Shah, MD's prescribing is 51% brand-name and 40% generic drugs by claim count, with $842K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Amy Shah, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Amy Shah, MD's most frequently prescribed drugs include Ozempic, Levothyroxine Sodium, Metformin Hcl Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Amy Shah, MD accept Medicare? ▼
Amy Shah, MD appears in CMS Medicare data with 1,587 Part D claims and 245 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Amy Shah, MD's credentials? ▼
Amy Shah, MD's NPI is 1437595311 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.